You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 9,987,229


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,987,229
Title:Process for preparing a medicament
Abstract: The present invention provides a process for preparing a particulate medicament that has greater homogeneity and a lower adhesion between the particles of the active ingredient and the carrier. The process comprises the steps of: (a) combining a pharmaceutically active ingredient in the form of an agglomerate of primary particles having an agglomerate particle size such that the agglomerate is capable of passing through a sieve having a mesh of 50-3000 .mu.m with a pharmaceutically acceptable particulate carrier, and (b) mixing the resultant material in a mixer to break up the agglomerate into primary particles dispersed in the pharmaceutically acceptable particulate carrier such that 90% or more of the pharmaceutically active ingredient exists as primary particles having a particle size of 50 .mu.m or less.
Inventor(s): Zeng; Xian-Ming (London, GB), Tee; Seah Kee (London, GB)
Assignee: Norton Healthcare Ltd. (London, GB)
Application Number:15/453,940
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,987,229

Introduction

United States Patent 9,987,229, like any other patent, is a complex document that outlines the intellectual property rights of an invention. To fully comprehend its significance, it is crucial to analyze its scope, claims, and the broader patent landscape it operates within.

Patent Overview

Patent Title and Abstract

The patent in question, US 9,987,229, is titled "Particulate medicament and process for preparing the same." The abstract typically provides a brief summary of the invention, which in this case involves a process for preparing a particulate medicament with greater homogeneity and lower adhesion between particles[2].

Scope of the Patent

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is often measured using metrics such as independent claim length and independent claim count, which can indicate the complexity and breadth of the invention[3].

Metrics for Measuring Scope

  • Independent Claim Length: Longer independent claims often indicate a narrower scope as they specify more detailed limitations.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, but this can also lead to increased complexity and potential litigation issues[3].

Scope Analysis of US 9,987,229

For US 9,987,229, the scope would be determined by the specific claims made in the patent. If the claims are narrow and detailed, the patent scope would be limited to the exact process and medicament described. Conversely, broader claims could encompass a wider range of processes and products.

Claims Analysis

Types of Claims

Patent claims are the legal definitions of the invention and are categorized into independent and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the independent claims.

Claim Structure of US 9,987,229

To understand the claims of US 9,987,229, one must review the patent document itself. Typically, the claims section will outline the specific steps, components, or characteristics of the particulate medicament and the process for preparing it. For example, if the patent claims a specific method of particle formation, any subsequent processes that use this method could potentially infringe on the patent.

Patent Landscape

Global Patent System

The patent landscape for US 9,987,229 includes not just the U.S. but also international jurisdictions. Tools like the Global Dossier and Common Citation Document (CCD) help in understanding the global patent family and prior art cited by various patent offices[4].

Related Patents and Prior Art

Using resources such as the USPTO's Patent Public Search tool, the European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE, one can identify related patents and prior art that may influence the scope and validity of US 9,987,229[4].

Allowance Rates and Examination Process

Understanding Allowance Rates

The probability of a patent being granted can be influenced by various factors, including the first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates can provide insights into the likelihood of similar patents being granted in the future[1].

Examination Process Impact

The examination process can significantly narrow the scope of patent claims. Studies have shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Industry Impact and Innovation

Licensing and Litigation

The breadth and clarity of patent claims can impact licensing and litigation costs. Overly broad or unclear claims can lead to increased litigation, potentially diminishing incentives for innovation[3].

Market Dominance

A well-defined and narrowly scoped patent like US 9,987,229 can help the patent holder maintain market dominance by protecting their specific invention from infringement.

Practical Considerations for Business Professionals

Conducting Preliminary Searches

Before developing a product similar to the one described in US 9,987,229, business professionals should conduct thorough preliminary searches using tools like the USPTO's Patent Public Search and international databases to ensure they are not infringing on existing patents[4].

Understanding Patent Assignments

Changes in ownership or assignments of patents can affect the enforcement and validity of the patent. The Patent Assignment Search website can be used to track such changes[4].

Key Takeaways

  • Patent Scope: Measured by independent claim length and count, it defines the breadth of protection.
  • Claims Analysis: Independent and dependent claims define the legal boundaries of the invention.
  • Global Landscape: Tools like Global Dossier and CCD help in understanding the global patent family.
  • Examination Process: Narrower claims at publication are associated with higher grant probabilities and shorter examination times.
  • Industry Impact: Clear and narrow claims can reduce litigation costs and maintain market dominance.

FAQs

What is the significance of independent claim length in patent scope?

Independent claim length is a metric used to measure patent scope. Longer independent claims typically indicate a narrower scope as they specify more detailed limitations.

How does the examination process affect patent claims?

The examination process tends to narrow the scope of patent claims, with longer examination durations resulting in more significant scope reductions.

What tools can be used to search for related patents and prior art?

Tools such as the USPTO's Patent Public Search, Global Dossier, and international databases like esp@cenet and PATENTSCOPE can be used to search for related patents and prior art.

Why is it important to conduct a preliminary patent search?

Conducting a preliminary patent search helps ensure that a new product or process does not infringe on existing patents, reducing the risk of litigation and potential legal costs.

How can changes in patent ownership affect the patent's validity?

Changes in patent ownership, tracked through the Patent Assignment Search, can affect the enforcement and validity of the patent, as new owners may have different priorities or legal standings.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. The Yale Journal of Law & Technology.
  2. Unified Patents Portal. (n.d.). US-9616024-B2. Unified Patents.
  3. SSRN. (2016, September 29). Patent Claims and Patent Scope. Social Science Research Network.
  4. USPTO. (2018, October 18). Search for patents. United States Patent and Trademark Office.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,987,229

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Teva Pharm AIRDUO DIGIHALER fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 208799-004 Jul 12, 2019 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Teva Pharm AIRDUO DIGIHALER fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 208799-005 Jul 12, 2019 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Teva Pharm AIRDUO DIGIHALER fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 208799-006 Jul 12, 2019 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Teva Pharm AIRDUO RESPICLICK fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 208799-001 Jan 27, 2017 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Teva Pharm AIRDUO RESPICLICK fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 208799-002 Jan 27, 2017 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Teva Pharm AIRDUO RESPICLICK fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 208799-003 Jan 27, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,987,229

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 498394 ⤷  Subscribe
Canada 2575957 ⤷  Subscribe
Cyprus 1113221 ⤷  Subscribe
Germany 602004031459 ⤷  Subscribe
Denmark 1699434 ⤷  Subscribe
European Patent Office 1699434 ⤷  Subscribe
Spain 2362038 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.